These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11401009)

  • 21. Interictal brain 5-HT1A receptors binding in migraine without aura: a 18F-MPPF-PET study.
    Lothe A; Merlet I; Demarquay G; Costes N; Ryvlin P; Mauguière F
    Cephalalgia; 2008 Dec; 28(12):1282-91. PubMed ID: 18727636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occupancy of agonist drugs at the 5-HT1A receptor.
    Bantick RA; Rabiner EA; Hirani E; de Vries MH; Hume SP; Grasby PM
    Neuropsychopharmacology; 2004 May; 29(5):847-59. PubMed ID: 14985704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
    Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
    Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain.
    Farde L; Ginovart N; Ito H; Lundkvist C; Pike VW; McCarron JA; Halldin C
    Psychopharmacology (Berl); 1997 Sep; 133(2):196-202. PubMed ID: 9342787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
    Sharp T; McQuade R; Bramwell S; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative imaging of 5-HT(1A) receptor binding in healthy volunteers with [(18)f]p-MPPF.
    Passchier J; van Waarde A; Pieterman RM; Elsinga PH; Pruim J; Hendrikse HN; Willemsen AT; Vaalburg W
    Nucl Med Biol; 2000 Jul; 27(5):473-6. PubMed ID: 10962253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
    Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
    Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response.
    Nakayama T; Suhara T; Okubo Y; Ichimiya T; Yasuno F; Maeda J; Takano A; Saijo T; Suzuki K
    Psychopharmacology (Berl); 2002 Dec; 165(1):37-42. PubMed ID: 12474116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-(2'-Methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido]ethyl] piperazine and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors.
    Thielen RJ; Fangon NB; Frazer A
    J Pharmacol Exp Ther; 1996 May; 277(2):661-70. PubMed ID: 8627543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase.
    Millan MJ; Newman-Tancredi A; Duqueyroix D; Cussac D
    Eur J Pharmacol; 2001 Jul; 424(1):13-7. PubMed ID: 11470255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride.
    Rabiner EA; Gunn RN; Wilkins MR; Sedman E; Grasby PM
    J Psychopharmacol; 2002 Sep; 16(3):195-9. PubMed ID: 12236624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects.
    Lothe A; Boni C; Costes N; Gorwood P; Bouvard S; Le Bars D; Lavenne F; Ryvlin P
    Neuroimage; 2009 Aug; 47(2):482-92. PubMed ID: 19409499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
    Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rigid analogues of buspirone and gepirone, 5-HT1A receptors partial agonists.
    Chilmonczyk Z; Krajewski KJ; Cybulski J
    Farmaco; 2002 Nov; 57(11):917-23. PubMed ID: 12484540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers.
    Sibon I; Benkelfat C; Gravel P; Aznavour N; Costes N; Mzengeza S; Booij L; Baker G; Soucy JP; Zimmer L; Descarries L
    Biol Psychiatry; 2008 Jun; 63(12):1135-40. PubMed ID: 18191817
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.